TSE:4559Pharmaceuticals
Zeria Pharmaceutical (TSE:4559) Q3 EPS Surge Challenges Recent Bearish Earnings Narratives
Zeria Pharmaceutical (TSE:4559) has put up a busy Q3 2026 earnings print, with revenue of ¥24,117 million and basic EPS of ¥86.59, alongside trailing twelve month revenue of ¥86,615 million and EPS of ¥164.79. The company has seen quarterly revenue move from ¥22,351 million in Q3 2025 to ¥24,117 million in Q3 2026, while basic EPS shifted from ¥49.12 to ¥86.59 over the same periods. This sets the stage for investors to weigh these headline gains against a trailing net margin that has eased...